In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype

By Hotz Birgit   Keilholz Ulrich   Fusi Alberto   Buhr Heinz   Hotz Hubert  

Gastric Cancer, Vol. 15, Iss. 3, 2012-07 ,pp. : 252-264

Springer Publishing Company

Access to resources Recommend Favorite

In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model

By                

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1743-1749

Spandidos Publications

Access to resources Recommend Favorite

In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR

By Balin-Gauthier Diane   Delord Jean-Pierre   Rochaix Philippe   Mallard Valérie   Thomas Fabienne   Hennebelle Isabelle   Bugat Roland   Canal Pierre   Allal Cuider  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 709-718

Springer Publishing Company

Access to resources Recommend Favorite

Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts

By                      

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 260-268

Spandidos Publications

Access to resources Recommend Favorite

Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models

By Chen Jianping   Smith Melissa   Kolinsky Kenneth   Adames Violeta   Mehta Nila   Fritzky Luke   Rashed Mohammad   Wheeldon Eric   Linn Michael   Higgins Brian  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 651-659

Springer Publishing Company

Access to resources Recommend Favorite